About
Gujarat Kidney and Super Speciality Limited is a regional healthcare provider operating a network of mid-sized multispeciality hospitals across central Gujarat. Established in 2019 and later renamed to reflect its expanding clinical scope, the company focuses on delivering integrated secondary and tertiary care. The organisation is promoted by Dr Pragnesh Yashwantsinh Bharpoda, Dr Bhartiben Pragnesh Bharpoda, Dr Yashwantsinh Motisinh Bharpoda, and Anitaben Yashwantsinh Bharpoda, who collectively bring strong medical and managerial expertise.
Today, the company runs seven hospitals and four in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand. Its network offers a total capacity of 490 beds, supported by 445 approved and 340 operational beds. Services span inpatient and outpatient care, diagnostics, surgical and critical care, and pharmacy operations within hospital premises. Its business model blends owned and acquired facilities, enabling scalable expansion and efficient integration of new units. With a growing regional footprint, strengthened by technology adoption and speciality-driven services, the company is positioned to meet rising healthcare needs in Gujarat’s semi-urban and urban markets.
IPO Schedule
| Issue open date | 2025-12-22 |
| Issue close date | 2025-12-24 |
| UPI mandate deadline | 2025-12-24 (5 PM) |
| Allotment finalization | 2025-12-26 |
| Refund initiation | 2025-12-29 |
| Share credit | 2025-12-29 |
| Listing date | 2025-12-30 |
| Mandate end date | 2026-01-09 |
| Lock-in end date for anchor investors (50%) | 2026-01-25 |
| Lock-in end date for anchor investors (remaining) | 2026-03-26 |
Financials
| Financial Year Ended | March 2024 | March 2025 | June 2025 |
|---|---|---|---|
| Total Assets | 20.53 | 55.34 | 61.59 |
| Revenue | 5.48 | 4.04 | 15.27 |
| Profit After Tax | 1.71 | 9.5 | 5.4 |
Issue Size
| Funds Raised in the IPO | Amount |
|---|---|
| Total issue size | 250.80 |
| Fresh Issue - Proceeds go to the company | 250.80 |
Utilisation of Proceeds
| Purpose | INR crores (%) |
|---|---|
| Acquisition of Parekhs Hospital, Ahmedabad | 77 (30.70%) |
| Part-payment for Ashwini Medical Centre | 12.4 (4.94%) |
| Capital expenditure for a new hospital in Vadodara | 30.1 (12%) |
| Robotics equipment at Vadodara hospital | 6.83 (2.72%) |
| Repayment/prepayment of secured borrowings | 1.2 (0.48%) |
| Acquisition of additional stake in Harmony Medicare (Bharuch) | 10.78 (4.30%) |
| General corporate purposes | 112.49 (44.86%) |
Strengths
- Strong capabilities in renal sciences with established urology subspecialties.
- Strategically located, right-sized hospitals providing efficient capital returns.
- Proven ability to attract, train, and retain skilled medical professionals.
- Continuous investment in infrastructure and clinical processes supporting affordable care.
- Strong operational and financial performance with a track record of growth.
Risks
- The company has acquired several hospitals from promoters and may continue such related-party acquisitions.
- Acquisitions and integrations involve operational, financial, and regulatory risks.
- Rapid expansion across multiple hospitals increases management and operational complexity.
- Dependence on promoter-led expertise poses concentration and continuity risks.
- Hospitals lacking certain departments may limit service breadth.
Allotment Status for Gujarat Kidney and Super Speciality
- To check your IPO allotment status:
- Visit the MUFG Intime India IPO Application Status page.
- Select the company name from the dropdown menu.
- Select and enter one of the following: PAN, Application Number, DP/Client ID, or Account Number/IFSC.
- Click Submit to view your allotment status.